|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00142870 |
|
Date of registration:
|
01/09/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Effectiveness of Bupropion in Treating Marijuana Dependent Individuals
|
|
Scientific title:
|
Effects of Bupropion on Marijuana Withdrawal Symptoms |
|
Date of first enrolment:
|
March 2005 |
|
Target sample size:
|
30 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00142870 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
David M Penetar |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Mclean Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Current marijuana use and dependence
- Marijuana use of at least 5 times in the past 7 days or more than 25 times per month
for the 3 years prior to enrollment
- Unsuccessful in a previous attempt to quit marijuana
Exclusion Criteria:
- Axis I disorder
- Any drug abuse or dependence other than marijuana
- Currently taking antipsychotic or antidepressant medication
- Heavy alcohol drinker (more than 20 drinks per week)
- Current nicotine dependence
- History of a seizure disorder
- Current or prior eating disorder (e.g., bulimia or anorexia nervosa)
- Heavy caffeine use (more than 300 mg per day)
- Life threatening or unstable medical illness
- Pregnant
Age minimum:
18 Years
Age maximum:
50 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Marijuana Abuse
|
|
Substance-Related Disorders
|
|
Intervention(s)
|
|
Drug: Bupropion
|
|
Primary Outcome(s)
|
|
Withdrawal severity
[Time Frame: on a daily basis for 14 days]
|
|
Secondary ID(s)
|
|
DPMC
|
|
NIDA-17275-1
|
|
R03-17275-1
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|